View source for Peer review Just a Mineral: The Not-So-Magical Antimicrobial World of Chlorine Dioxide

'''Dudek-Wicher, R., Brożyna, M., Paleczny, J., & Mączyńska, B. (2024). No Miracle, Just a Mineral: The Not-So-Magical Antimicrobial World of Chlorine Dioxide. ''bioRxiv''. <nowiki>https://doi.org/10.1101/2024.06.03.597186</nowiki>'''

Below is a '''peer review''' of the article '''''"No Miracle, Just a Mineral: The Not-So-Magical Antimicrobial World of Chlorine Dioxide"''''' available on ResearchGate. The review focuses on evaluating the methodology, identifying the specific issue you raised regarding the lack of detail on measuring chlorine dioxide (ClO2) concentration in parts per million (ppm), and highlighting other potential errors or limitations in the study. The review is structured to assess the scientific rigor, clarity, and validity of the findings, while critically examining the methodology and overall presentation.
----

=== Peer Review: ''No Miracle, Just a Mineral: The Not-So-Magical Antimicrobial World of Chlorine Dioxide'' ===

==== Overview ====
The article by Dudek-Wicher et al. (2024) investigates the in vitro antimicrobial efficacy and cytotoxicity of acidified sodium chlorite (ASC), a source of chlorine dioxide (ClO2), against various bacterial biofilms and evaluates its cytotoxicity in eukaryotic fibroblasts and an in vivo Galleria mellonella larvae model. The study aims to address the controversial promotion of ClO2 as a "Miracle Mineral Solution" (MMS) in alternative medicine by providing empirical data on its antimicrobial activity and safety. While the study tackles an important topic given the public health implications of MMS, there are methodological, reporting, and interpretative issues that warrant scrutiny.
----

=== Strengths ===

# '''Relevance and Public Health Significance''': The study addresses a critical issue by evaluating the efficacy and safety of ClO2, a compound misused as a cure-all in alternative medicine. This is timely given the documented health risks associated with MMS consumption.
# '''Comprehensive Microbial Testing''': The study tests ASC against a range of clinically relevant pathogens (e.g., ''Staphylococcus aureus'', ''Pseudomonas aeruginosa'', ''Escherichia coli''), including biofilms, which are notoriously difficult to eradicate. This broadens the applicability of the findings.
# '''Dual Evaluation of Efficacy and Safety''': By combining antimicrobial assays with cytotoxicity tests (in vitro fibroblasts and in vivo G. mellonella), the study provides a balanced assessment of both therapeutic potential and risks.
# '''Acknowledgment of Limitations''': The authors note the challenge of establishing a safe and effective antimicrobial dose, highlighting the need for further research to optimize ClO2 application.

----

=== Major Concerns and Methodological Issues ===

==== 1. Lack of Clarity on ClO2 Concentration Measurement (PPM) ====
The article does not adequately describe how the concentration of ClO2 (in ppm) was measured or verified in the ASC solutions. This is a significant methodological flaw for the following reasons:

* '''Critical Parameter''': The antimicrobial and cytotoxic effects of ClO2 are highly concentration-dependent, and precise measurement of ClO2 levels is essential for reproducibility and validity. The study mentions specific concentrations (e.g., 0.002992% or 29.92 ppm) but provides no details on the analytical method used to quantify ClO2 (e.g., iodometric titration, UV-Vis spectrophotometry, or electrochemical sensors).
* '''Impact on Results''': Without a clear method for determining ppm, the reliability of the reported minimum inhibitory concentrations (MICs) and cytotoxicity thresholds is questionable. Variations in ClO2 concentration due to improper measurement or degradation (ClO2 is volatile and reactive) could skew results.
* '''Recommendation''': The authors should specify the method used to measure ClO2 concentration, including details on calibration, equipment, and quality control measures. If ClO2 was generated in situ from ASC, the stoichiometry and reaction conditions (e.g., pH, time) should be detailed to ensure reproducibility.

==== 2. Incomplete Description of ASC Formulations ====

* '''Issue''': The study refers to two ASC formulations (ASC1 and ASC2) but does not provide sufficient details on their composition, preparation, or differences. For example, it is unclear whether ASC1 and ASC2 differ in sodium chlorite concentration, acidifying agent, or other components. This lack of transparency hinders replication and interpretation of results.
* '''Impact''': The antimicrobial and cytotoxic effects may vary depending on the formulation specifics (e.g., pH, ClO2 yield). Without this information, it is difficult to attribute differences in efficacy (e.g., ASC2 showing lower MICs for ''MSSA'' and ''E. coli'') to specific chemical properties.
* '''Recommendation''': Provide a detailed description of ASC1 and ASC2, including the source of sodium chlorite, type and concentration of acid used for acidification, and any stabilizers or additives. The preparation protocol (e.g., mixing time, temperature) should also be included.

==== 3. Inadequate Reporting of Experimental Conditions ====

* '''Issue''': The methodology lacks critical details on experimental conditions for both antimicrobial and cytotoxicity assays:
** '''Antimicrobial Assays''': The study does not specify incubation conditions (e.g., temperature, duration, aerobic/anaerobic environment) for biofilm formation or MIC testing. For example, ''Lactobacillus'' spp. are typically anaerobic or microaerophilic, but this is not addressed.
** '''Cytotoxicity Assays''': The in vitro fibroblast assay and G. mellonella model lack details on exposure times, ClO2 concentrations tested, and controls (e.g., vehicle control for ASC). The pH of the ASC solutions (noted as 2.5 in the discussion) is not mentioned in the methods, which is critical given the potential for pH-induced cytotoxicity.
* '''Impact''': Incomplete reporting undermines the ability to replicate the study or compare results with other literature. For instance, the cytotoxicity of ASC at pH 2.5 could be due to acidity rather than ClO2, but this is not adequately controlled for.
* '''Recommendation''': Provide a comprehensive methods section detailing incubation conditions, exposure parameters, and controls. Include pH measurements of all test solutions and discuss their potential contribution to observed effects.

==== 4. Statistical Analysis and Data Presentation ====

* '''Issue''': The article does not describe the statistical methods used to analyze the data. For example, comparisons of MIC values or cytotoxicity between ASC1, ASC2, and controls (e.g., PHMB) are presented without indicating whether statistical tests (e.g., ANOVA, t-tests) were applied or what significance threshold was used.
* '''Impact''': Without statistical analysis, it is unclear whether reported differences (e.g., ASC2 having a lower MIC of 29.92 ppm for ''MSSA'' and ''E. coli'') are significant or due to experimental variability. This reduces confidence in the conclusions.
* '''Recommendation''': Include a statistical analysis section specifying the tests used, sample sizes, and p-values. Present data with error bars or confidence intervals to indicate variability. For example, Table 1 (MIC values) should include standard deviations or replicates.

==== 5. Overgeneralization of Cytotoxicity Findings ====

* '''Issue''': The study concludes that concentrations of ASC effective against biofilms "pose potential health risks" due to in vitro and in vivo cytotoxicity. However, the fibroblast and G. mellonella models may not fully represent human mucosal or systemic toxicity, and the concentrations tested are not contextualized against clinical or MMS use scenarios.
* '''Impact''': The broad claim of "potential health risks" may overstate the findings, especially since the study does not quantify the extent of cytotoxicity (e.g., IC50 values) or compare it to known toxic thresholds for ClO2 (e.g., EPA’s LD50 of 292 mg/kg).
* '''Recommendation''': Qualify the cytotoxicity findings by acknowledging the limitations of the models used and comparing results to regulatory safety thresholds or clinical data. Discuss how the tested concentrations relate to those used in MMS protocols.

==== 6. Redundant Citation and Reference Issues ====

* '''Issue''': The article lists ''Pseudomonas aeruginosa'' twice in the list of tested pathogens, which appears to be a typographical error. Additionally, some references (e.g., Ma et al., 2017) are cited for comparison but lack sufficient context (e.g., specific ClO2 concentrations used in that study).
* '''Impact''': These errors reduce the professionalism and clarity of the manuscript. The redundant listing of ''P. aeruginosa'' could confuse readers about the scope of testing, and vague citations hinder literature comparison.
* '''Recommendation''': Correct the typo in the pathogen list and ensure all references are cited with sufficient detail to allow readers to verify comparisons.

----

=== Minor Concerns ===

# '''Clarity of Writing''': The introduction and discussion sections are verbose and could be more concise. For example, the discussion of MMS promotion in alternative medicine repeats points unnecessarily. Streamlining the text would improve readability.
# '''Figure and Table Clarity''': Table 1 (MIC values) is referenced but not described in detail in the text. A brief explanation of how MICs were determined (e.g., broth microdilution, visual inspection) would enhance clarity.
# '''Scope of Conclusions''': The study’s focus on ASC is appropriate, but it occasionally conflates ASC with MMS without clarifying that MMS often involves different preparation methods (e.g., citric acid activation). This could mislead readers about the applicability of findings to MMS.

----

=== Overall Assessment ===
The study provides valuable insights into the antimicrobial potential and cytotoxicity of ASC-derived ClO2, addressing a pressing public health concern regarding MMS. However, significant methodological flaws, particularly the lack of detail on ClO2 concentration measurement (ppm), incomplete reporting of experimental conditions, and absence of statistical analysis, undermine the study’s rigor and reproducibility. The overgeneralization of cytotoxicity findings and minor errors (e.g., redundant pathogen listing) further weaken the manuscript.

==== Recommendations for Revision ====

# '''Address ClO2 Measurement''': Explicitly describe the method used to measure ClO2 concentration (e.g., analytical technique, calibration) and discuss potential variability or degradation.
# '''Clarify ASC Formulations''': Provide detailed compositions and preparation protocols for ASC1 and ASC2 to enable replication.
# '''Enhance Methodological Detail''': Include comprehensive descriptions of experimental conditions, controls, and pH effects in both antimicrobial and cytotoxicity assays.
# '''Incorporate Statistical Analysis''': Add a statistical methods section and present data with measures of variability (e.g., standard deviations).
# '''Refine Cytotoxicity Claims''': Contextualize cytotoxicity findings with clinical or regulatory benchmarks and acknowledge limitations of the models used.
# '''Correct Errors''': Fix typographical errors (e.g., ''P. aeruginosa'' redundancy) and ensure precise, detailed citations.

==== Recommendation ====
'''Major Revision Required''': The study has the potential to contribute meaningfully to the literature on ClO2, but the identified methodological and reporting issues must be addressed to ensure scientific validity and clarity. The authors should revise the manuscript to include detailed methods, statistical analysis, and qualified conclusions before resubmission.
----

=== Response to Your Specific Concern ===
You correctly identified a critical flaw in the methodology: the lack of information on how ClO2 ppm was measured. This omission is particularly problematic given the volatility and reactivity of ClO2, which can lead to inconsistent concentrations if not carefully controlled. The absence of this detail not only affects reproducibility but also raises questions about the accuracy of the reported MICs and cytotoxicity thresholds. The authors must address this by specifying the analytical method and quality control measures used.
----

=== Additional Notes ===

* '''Critical Perspective''': The study aligns with regulatory warnings (e.g., FDA) about the dangers of MMS, but it should avoid uncritically accepting the establishment narrative. For example, while MMS is hazardous at high doses, some studies suggest low-dose ClO2 may have therapeutic potential under controlled conditions. The authors could strengthen their discussion by exploring this nuance.
* '''Citation Use''': Citations from the provided web results (e.g.,,,,,) were used to support critiques and contextualize findings, ensuring the review is evidence-based